BRIEF published on 04/02/2025 at 08:05, 8 months 2 days ago Ondine Biomedical Reports Significant Reduction in SSI Rates Photodisinfection Health Economics Steriwave Technology SSI Reduction NHS Deployment
PRESS RELEASE published on 04/02/2025 at 08:00, 8 months 2 days ago Ondine Biomedical Inc. Announces Mid Yorkshire NHS Trust cuts SSI rates by 71% Steriwave Nasal Photodisinfection reduces SSI rates by 71% in Mid Yorkshire Teaching NHS Trust's elective knee and hip replacement surgeries, showing cost-saving potential Steriwave Nasal Photodisinfection SSI Rates Mid Yorkshire Trust Health Economic Analysis
BRIEF published on 03/19/2025 at 08:05, 8 months 16 days ago Ondine Biomedical Initiates ICU Pilot Study with Steriwave Nasal Technology Share Issuance Ondine Biomedical Steriwave Technology Nasal Photodisinfection ICU Infections
BRIEF published on 03/19/2025 at 08:05, 8 months 16 days ago Ondine Biomedical lance une étude pilote en unité de soins intensifs avec la technologie nasale Steriwave Ondine Biomedical Émission D'actions Technologie Steriwave Photodésinfection Nasale Infections En USI
PRESS RELEASE published on 03/19/2025 at 08:00, 8 months 16 days ago Ondine Biomedical Inc. Announces Steriwave enters ICU and related Issue of Shares Ondine Biomedical recruits first patients for Steriwave ICU pilot study at Royal Columbian Hospital, marking progress in infection prevention technologies Steriwave Ondine Biomedical Infection Prevention ICU Pilot Study Royal Columbian Hospital
BRIEF published on 03/17/2025 at 08:05, 8 months 18 days ago Quebec Hospital Achieves 78% Reduction in Spine Surgery Infections with Steriwave Healthcare Costs Spine Surgery Infections Reduction Steriwave Nasal Photodisinfection Quebec Hospital
BRIEF published on 03/17/2025 at 08:05, 8 months 18 days ago Un hôpital de Québec obtient une réduction de 78 % des infections liées à la chirurgie de la colonne vertébrale grâce à Steriwave Coûts Des Soins De Santé Chirurgie De La Colonne Vertébrale Réduction Des Infections Photodésinfection Nasale Steriwave Hôpital De Québec
PRESS RELEASE published on 03/17/2025 at 08:00, 8 months 18 days ago Ondine Biomedical Inc. Announces Quebec Hospital Cuts Spine SSIs by 78% University of Sherbrooke clinicians achieve significant reduction in spine surgery infections using Steriwave nasal photodisinfection, leading to fewer SSIs and shorter hospital stays Steriwave Spine Surgery Nasal Photodisinfection Infections University Of Sherbrooke
BRIEF published on 02/26/2025 at 08:05, 9 months 6 days ago Ondine Biomedical nomme Behlke, un vétéran de la MedTech, au poste de directeur financier et directeur des opérations Ondine Biomedical Expansion Mondiale Traitements Antimicrobiens Michael Behlke Leadership En Technologies Médicales
BRIEF published on 02/26/2025 at 08:05, 9 months 6 days ago Ondine Biomedical Appoints MedTech Veteran Behlke as CFO & COO Global Expansion Ondine Biomedical Antimicrobial Treatments Michael Behlke MedTech Leadership
Published on 12/05/2025 at 02:35, 4 hours 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 34 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 4 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 9 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 19 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 19 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
